Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $61,434 - $101,132
607 Added 13.59%
5,073 $602,000
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $86,052 - $116,363
1,008 Added 29.15%
4,466 $475,000
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $127,481 - $191,524
-1,834 Reduced 34.66%
3,458 $343,000
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $82,623 - $108,504
-857 Reduced 13.94%
5,292 $546,000
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $186,400 - $252,513
-1,573 Reduced 20.37%
6,149 $747,000
Q1 2023

May 12, 2023

BUY
$135.66 - $197.02 $13,701 - $19,899
101 Added 1.33%
7,722 $1.19 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $85,825 - $152,279
725 Added 10.51%
7,621 $1.37 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $103,075 - $169,519
873 Added 14.49%
6,896 $816,000
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $23,660 - $35,671
202 Added 3.47%
6,023 $860,000
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $153,269 - $284,880
1,212 Added 26.3%
5,821 $1 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $181,107 - $295,545
-802 Reduced 14.82%
4,609 $1.17 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $377,008 - $823,114
1,699 Added 45.77%
5,411 $2.08 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $49,885 - $90,232
384 Added 11.54%
3,712 $872,000
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $19,106 - $32,546
175 Added 5.55%
3,328 $436,000
Q4 2020

Feb 11, 2021

BUY
$65.74 - $169.86 $207,278 - $535,568
3,153 New
3,153 $329,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.